Related Experiment Video
Updated: Jun 25, 2026
07:40
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
Study design and methods of the Ansan Geriatric Study (AGE study).
Changsu Han1, Sangmee Ahn Jo, Nan Hee Kim
1Department of Neurology, Korea University Medical College, 516, Gojan-dong, Danwon-gu, Ansan-shi, Gyeonggi-do 425-707, Republic of Korea. hancs@korea.ac.kr
BMC Neurology
|February 25, 2009
Summary
The Ansan Geriatric Study (AGE study) describes the prevalence and risk factors of geriatric diseases in elderly Koreans. This cohort provides data for health policy and social services planning.
Area of Science:
- Gerontology
- Epidemiology
- Public Health
Background:
- The Ansan Geriatric Study (AGE study) was initiated to understand health and aging in elderly Koreans.
- Focuses on the prevalence, incidence, and risk factors of common geriatric diseases.
Purpose of the Study:
- To describe the prevalence, incidence, and risk factors of geriatric diseases in elderly Koreans.
- To provide comprehensive longitudinal health data for policy formulation and planning of health and welfare services.
Main Methods:
- Population-based prospective cohort study design.
- Recruitment of elderly Koreans aged 60-84 years, starting May 2002.
- Standardized procedures for data collection across study waves, enrolling 2,767 participants at screening.
Main Results:
- Estimation of prevalence and related factors for geriatric diseases in the elderly Korean population.
- Detailed characterization of health information through comprehensive data collection.
Conclusions:
- The AGE study provides a robust dataset for understanding geriatric health in Korea.
- Findings will inform policy development for health, welfare, and social services for the elderly population.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...